143 related articles for article (PubMed ID: 7884023)
1. Venlafaxine for treatment-resistant unipolar depression.
Nierenberg AA; Feighner JP; Rudolph R; Cole JO; Sullivan J
J Clin Psychopharmacol; 1994 Dec; 14(6):419-23. PubMed ID: 7884023
[TBL] [Abstract][Full Text] [Related]
2. Dual-dual action? Combining venlafaxine and mirtazapine in the treatment of depression.
Malhi GS; Ng F; Berk M
Aust N Z J Psychiatry; 2008 Apr; 42(4):346-9. PubMed ID: 18330778
[TBL] [Abstract][Full Text] [Related]
3. Low frequency (1-Hz), right prefrontal repetitive transcranial magnetic stimulation (rTMS) compared with venlafaxine ER in the treatment of resistant depression: a double-blind, single-centre, randomized study.
Bares M; Kopecek M; Novak T; Stopkova P; Sos P; Kozeny J; Brunovsky M; Höschl C
J Affect Disord; 2009 Nov; 118(1-3):94-100. PubMed ID: 19249105
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of high dose of venlafaxine XL in treatment resistant major depression.
Mbaya P
Hum Psychopharmacol; 2002 Oct; 17(7):335-9. PubMed ID: 12415551
[TBL] [Abstract][Full Text] [Related]
5. Extended-release venlafaxine in relapse prevention for patients with major depressive disorder.
Simon JS; Aguiar LM; Kunz NR; Lei D
J Psychiatr Res; 2004; 38(3):249-57. PubMed ID: 15003430
[TBL] [Abstract][Full Text] [Related]
6. A double-blind, placebo-controlled evaluation of the effects of orally administered venlafaxine on sleep in inpatients with major depression.
Luthringer R; Toussaint M; Schaltenbrand N; Bailey P; Danjou PH; Hackett D; Guichoux JY; Macher JP
Psychopharmacol Bull; 1996; 32(4):637-46. PubMed ID: 8993085
[TBL] [Abstract][Full Text] [Related]
7. Comparison of short-term venlafaxine versus lithium monotherapy for bipolar II major depressive episode: a randomized open-label study.
Amsterdam JD; Shults J
J Clin Psychopharmacol; 2008 Apr; 28(2):171-81. PubMed ID: 18344727
[TBL] [Abstract][Full Text] [Related]
8. Venlafaxine efficacy and tolerability in the treatment of post-stroke depression.
Kucukalić A; Bravo-Mehmedbasić A; Kulenović AD; Suljić-Mehmedika E
Psychiatr Danub; 2007 Jun; 19(1-2):56-60. PubMed ID: 17603417
[TBL] [Abstract][Full Text] [Related]
9. A double-blind, placebo-controlled comparison of venlafaxine and fluoxetine treatment in depressed outpatients.
Nemeroff CB; Thase ME;
J Psychiatr Res; 2007; 41(3-4):351-9. PubMed ID: 16165158
[TBL] [Abstract][Full Text] [Related]
10. Eight-week, placebo-controlled, double-blind comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR.
Hewett K; Chrzanowski W; Schmitz M; Savela A; Milanova V; Gee M; Krishen A; Millen L; Leary MO; Modell J
J Psychopharmacol; 2009 Jul; 23(5):531-8. PubMed ID: 18635695
[TBL] [Abstract][Full Text] [Related]
11. Comparison of venlafaxine and imipramine in the acute treatment of major depression in outpatients.
Schweizer E; Feighner J; Mandos LA; Rickels K
J Clin Psychiatry; 1994 Mar; 55(3):104-8. PubMed ID: 8071246
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of venlafaxine treatment in a broad spectrum of depressed patients: a meta-analysis.
Entsuah AR; Rudolph RL; Chitra R
Psychopharmacol Bull; 1995; 31(4):759-66. PubMed ID: 8851650
[TBL] [Abstract][Full Text] [Related]
13. Venlafaxine in the treatment of depressive and vasomotor symptoms in women with perimenopausal depression.
Ladd CO; Newport DJ; Ragan KA; Loughhead A; Stowe ZN
Depress Anxiety; 2005; 22(2):94-7. PubMed ID: 16094663
[TBL] [Abstract][Full Text] [Related]
14. Depressed patients perception of the efficacy of electroconvulsive therapy and venlafaxine therapy.
Kopecek M; Cerná L; Sulak J; Raszka M; Bares M; Seifertová D
Neuro Endocrinol Lett; 2007 Dec; 28(6):889-94. PubMed ID: 18063943
[TBL] [Abstract][Full Text] [Related]
15. A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder.
Pollack MH; Lepola U; Koponen H; Simon NM; Worthington JJ; Emilien G; Tzanis E; Salinas E; Whitaker T; Gao B
Depress Anxiety; 2007; 24(1):1-14. PubMed ID: 16894619
[TBL] [Abstract][Full Text] [Related]
16. Randomized placebo-controlled trial of escitalopram and venlafaxine XR in the treatment of generalized anxiety disorder.
Bose A; Korotzer A; Gommoll C; Li D
Depress Anxiety; 2008; 25(10):854-61. PubMed ID: 18050245
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of open-label venlafaxine in subjects with major depressive disorder: associations with neuroendocrine response to serotonergic and noradrenergic probes.
Grossman R; Reynolds D; Goodman M; New A; Silverman J; Schmeidler J; Mitropoulou V; Siever LJ
Psychiatry Res; 2004 Sep; 128(2):203-6. PubMed ID: 15488964
[TBL] [Abstract][Full Text] [Related]
18. The efficacy of fluoxetine combined with a heterocyclic antidepressant in treatment-resistant depression: a retrospective analysis.
Zajecka JM; Jeffries H; Fawcett J
J Clin Psychiatry; 1995 Aug; 56(8):338-43. PubMed ID: 7635848
[TBL] [Abstract][Full Text] [Related]
19. Mirtazapine versus venlafaxine in hospitalized severely depressed patients with melancholic features.
Guelfi JD; Ansseau M; Timmerman L; Kørsgaard S;
J Clin Psychopharmacol; 2001 Aug; 21(4):425-31. PubMed ID: 11476127
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and tolerability of once-daily venlafaxine extended release (XR) in outpatients with major depression. The Venlafaxine XR 209 Study Group.
Thase ME
J Clin Psychiatry; 1997 Sep; 58(9):393-8. PubMed ID: 9378690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
